Related Experiment Videos
Treatment of severe proliferative lupus nephritis: the current state
1Department of Medicine, Tuen Mun Hospital, Hong Kong, SAR, China. ccmok@netvigator.com
Annals of the Rheumatic Diseases
|August 19, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus.
Lupus science & medicine·2024
Low-dose corticosteroid and mycophenolate for primary treatment of minimal change disease.
QJM : monthly journal of the Association of Physicians·2019
Systemic lupus erythematosus: what should family physicians know in 2018?
Hong Kong medical journal = Xianggang yi xue za zhi·2018
Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.
Journal of autoimmunity·2018
Validation of systemic Juvenile Arthritis Disease Activity Score 10 in adults with Still's disease.
Annals of the rheumatic diseases·2026
SDH inhibition quenches rheumatoid arthritis flare-associated IL-1β+IFN-γ+ macrophages via NF-κB/STAT4.
Annals of the rheumatic diseases·2026
Immune reset after deep B-lineage depletion: remission is not reprogramming.
Annals of the rheumatic diseases·2026
Fatty Acid Metabolic Reprogramming in Rheumatoid Arthritis: Integrating Inflammation, Resolution Failure, and Joint Destruction.
Journal of inflammation research·2026
Sporadic lymphangioleiomyomatosis with lymphocyte-predominant pleural effusion misdiagnosed as tuberculosis: a case report.
Respiratory medicine case reports·2026
Epitope-Specific Thyroid Peroxidase Antibodies Reveal Functional Heterogeneity Within a Patient-Derived Monoclonal Repertoire.
Clinical and experimental immunology·2026